Innovating Works
HORIZON-INFRA-2021-EOSC-0...
HORIZON-INFRA-2021-EOSC-01-06: FAIR and open data sharing in support of cancer research
Sólo fondo perdido 0 €
Comunidad autónoma
Esta convocatoria está cerrada Esta línea ya está cerrada por lo que no puedes aplicar. Cerró el pasado día 23-09-2021.
Se espera una próxima convocatoria para esta ayuda, aún no está clara la fecha exacta de inicio de convocatoria.
Por suerte, hemos conseguido la lista de proyectos financiados!
Presentación: Consorcio Consorcio: Esta ayuda está diseñada para aplicar a ella en formato consorcio..
Esta ayuda financia Proyectos:

ExpectedOutcome:Project results are expected to contribute to all the following expected outcomes:

researchers, healthcare professionals, cancer patients and survivors contributing to cancer research regularly interact with EOSC to store, share, access, analyse and process research data and other research digital objects from their own discipline, across disciplines and national borders;open and FAIR data are the new norm for research conducted under this mission area;EU-wide sharing of research data relevant to this area is shown to be a critical mechanism to facilitate cancer research across Member States and Associated Countries;contribute to guaranteeing safety of patients’ data while at the same time contributing to research advancement. Engaging with patients/survivors in the sharing, access and use of data;EOSC grows into a trusted research and innovation data space and service platform in Europe that supports the interdisciplinary community involved in this mission area;contribute to the Horizon Europe EOSC Partnership and other relevant partnerships related to cancer research.
Scope:Reuse of research, clinical, epidemiological and socio-economic data w... ver más

ExpectedOutcome:Project results are expected to contribute to all the following expected outcomes:

researchers, healthcare professionals, cancer patients and survivors contributing to cancer research regularly interact with EOSC to store, share, access, analyse and process research data and other research digital objects from their own discipline, across disciplines and national borders;open and FAIR data are the new norm for research conducted under this mission area;EU-wide sharing of research data relevant to this area is shown to be a critical mechanism to facilitate cancer research across Member States and Associated Countries;contribute to guaranteeing safety of patients’ data while at the same time contributing to research advancement. Engaging with patients/survivors in the sharing, access and use of data;EOSC grows into a trusted research and innovation data space and service platform in Europe that supports the interdisciplinary community involved in this mission area;contribute to the Horizon Europe EOSC Partnership and other relevant partnerships related to cancer research.
Scope:Reuse of research, clinical, epidemiological and socio-economic data within and across disciplines and borders require openness, infrastructure capacity, better handling, careful management, machine actionability and seamless access to services all along the data life cycle. The Horizon Europe mission areas recognise upfront that providing access to data, knowledge and digital services through federated infrastructures is a key enabling condition for success. In addition, European Partnerships tackling complex societal challenges through multi-disciplinary approaches are facing important challenges in the European R&I systems, including poor data interoperability. In recent years, different scientific communities have started developing ‘thematic clouds’ or ‘data spaces’ within their domain of research and innovation. The EOSC provides the enabling framework to share, connect and upscale best practices and services by the communities to implement FAIR principles for (open, when possible) data sharing and management. The development of this framework is advancing rapidly as EOSC enters its second phase of implementation. Access to an initial EOSC federation of research infrastructures and their services is being consolidated and concepts such as FAIR data management and FAIR-by-design digital research outputs (data, publications, software, code, protocols, etc.) become more prominent.

The overall objective of this topic is to accelerate research and innovation under this mission area through better access, management, interoperability and reuse of digital information, to be achieved by using and integrating EOSC resources ranging from EOSC federated infrastructures, services and data to guidelines, best practices, tools and metrics for the management of FAIR and open data. This should be achieved through cross-domain, strategic use cases of direct relevance to the mission areas and the European Partnerships supporting this mission area on cancer.

The use cases should demonstrate the value of sharing FAIR and open research data, help to establish data sharing and management practices within the involved communities and across the Member States and Associated Countries, leveraging European research infrastructures and e-infrastructures. The use cases should provide feedback to the EOSC Partnership on the desired future evolution of EOSC. Special attention shall be put on aspects of data harmonisation, integration of data collection, data quality assurance, data privacy and security, big-data analysis and machine learning methods, as well as on the socio-economic dimension of the use case. Proposals should also foster the creation of user environments that researchers in this field can then use in order to seamlessly interact with digital information in the framework of the EOSC ecosystem.

Proposals should provide for activities to collaborate with relevant European Partnerships. Synergies with Horizon Europe Cluster 1 activities and other relevant initiatives, including actions stemming from Cohesion policy programmes are welcome. The activities should contribute to the consolidation of a European Health Data Space which is well articulated with the EOSC. They should build on results of relevant Horizon 2020 projects, including those providing pilots/models for linking clinical data and samples to cancer research, on initiatives for cancer such as the European Cancer Information System with the European Network of Cancer Registries, the European Reference Networks, the Innovative Partnership for Action Against Cancer (iPAAC) Joint Action and on the lessons learned from the ongoing European COVID-19 Data Platform, the EU Platform for Rare Diseases’ Registration and other initiatives in other disease areas. Proposers should consider already established ESFRI research infrastructures and efforts by relevant ESFRI cluster projects.

To ensure complementarity of outcomes, proposals are expected to cooperate and align with activities of the EOSC Partnership and to coordinate with relevant initiatives and projects contributing to the development of EOSC. In particular, in areas such as data interoperability, metadata and vocabularies, the use of persistent identifiers or Authentication and Authorisation Infrastructure (AAI), proposals should coordinate and establish a feedback mechanism with the awarded proposal/s from the topic HORIZON-INFRA-2021-EOSC-01-05 in order to ensure alignment with EOSC policies and to identify common useful tools and resources as well as relevant data repositories that comply with EOSC guidelines. Proposals are also expected to engage and/or align where appropriate with projects funded under the Other action "FAIR and open data sharing in support of European preparedness for COVID-19 and other infectious diseases" in this Work Programme, for a synergetic development of the area of Health within EOSC.

Grants awarded under this topic should also cooperate with the actions awarded under topic HORIZON-INFRA-2021-SERV-01-01 to identify and better exploit related synergies, share results and to avoid overlaps. To this extent, proposals should provide for dedicated activities and earmark appropriate resources.


Cross-cutting Priorities:Co-programmed European PartnershipsEOSC and FAIR data


ver menos

Temáticas Obligatorias del proyecto: Temática principal:

Características del consorcio

Ámbito Comunidad autónoma :
Solo pueden aplicar a esta linea las empresas con sede en:
Tipo y tamaño de organizaciones: El diseño de consorcio necesario para la tramitación de esta ayuda necesita de:
Empresas Micro, Pequeña, Mediana, Grande
Centros Tecnológicos
Universidades
Organismos públicos

Características del Proyecto

Requisitos de diseño: Duración: ¿Quieres ejemplos? Puedes consultar aquí los últimos proyectos conocidos financiados por esta línea, sus tecnologías, sus presupuestos y sus compañías.
Capítulos financiables: Los capítulos de gastos financiables para esta línea son:
Personnel costs.
Subcontracting costs.
Purchase costs.
Other cost categories.
Indirect costs.
Madurez tecnológica: La tramitación de esta ayuda requiere de un nivel tecnológico mínimo en el proyecto de TRL 4:. Es el primer paso para determinar si los componentes individuales funcionarán juntos como un sistema en un entorno de laboratorio. Es un sistema de baja fidelidad para demostrar la funcionalidad básica y se definen las predicciones de rendimiento asociadas en relación con el entorno operativo final. + info.
TRL esperado:

Características de la financiación

Intensidad de la ayuda: Sólo fondo perdido + info
Fondo perdido:
0% 25% 50% 75% 100%
Para el presupuesto subvencionable la intensidad de la ayuda en formato fondo perdido podrá alcanzar como minimo un 100%.
The funding rate for RIA projects is 100 % of the eligible costs for all types of organizations. The funding rate for RIA projects is 100 % of the eligible costs for all types of organizations.
Garantías:
No exige Garantías
No existen condiciones financieras para el beneficiario.

Información adicional de la convocatoria

Efecto incentivador: Esta ayuda no tiene efecto incentivador. + info.
Respuesta Organismo: Se calcula que aproximadamente, la respuesta del organismo una vez tramitada la ayuda es de:
Meses de respuesta:
Muy Competitiva:
No Competitiva Competitiva Muy Competitiva
No conocemos el presupuesto total de la línea
Minimis: Esta línea de financiación NO considera una “ayuda de minimis”. Puedes consultar la normativa aquí.

Otras ventajas

Sello PYME: Tramitar esta ayuda con éxito permite conseguir el sello de calidad de “sello pyme innovadora”. Que permite ciertas ventajas fiscales.